-
Johnson & Johnson Highlights Commitment to Transform Treatment of Retinal Diseases at ARVO 2024
04 May 2024 02:47 GMT
Company to present, across eight data presentations, new real-world research on the economic value of genetic testing for retinal diseases and the role of automatic deep-learning based algorithms for geographic atrophy
Johnson & Johnson to debut …
-
Financial Services and Insurance Firms Continue to Leverage AI to Enhance Operations – Research Study
04 May 2024 18:53 GMT
May 4, 2024 @ 2:02 pm By Omar Faridi
CBInsights says that they mined earnings calls, analyzed business relationships, and dug into investments and acquisitions in order to survey the AI [artificial intelligence] activities of some of the world’s largest …
-
Johnson & Johnson’s latest gambit to solve its massive talcum powder asbestos issue: A $6.5 billion settlement, paid out over 25 years
01 May 2024 23:02 GMT
Johnson & Johnson has a multibillion-dollar problem with its talcum powder and it just admitted that the best solution is also a multibillion-dollar one. The pharmaceutical giant, J&J for short, proposed a new way to settle thousands of pending …
-
Johnson & Johnson submits regulatory applications to European Medicines Agency for TREMFYA® (guselkumab) for treatment of patients with ulcerative colitis and Crohn's disease
01 May 2024 17:12 GMT
… years.1 Efficacy, safety, pharmacokinetics, immunogenicity, and biomarkers are … 47;johnson-johnson-innovative-medicine. Follow us at @JNJInnovMed. Janssen Research & Development, … Accessed April 2024.
Japan Pharmaceuticals and Medical Devices Agency. …
-
Orthopedic Implants Market Size to Reach $61.88 Billion Globally by 2030: Latest Report by Vantage Market Research
03 May 2024 09:21 GMT
Orthopedic Implants Market Size to Grow by $61.88 Bn | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, And Trends
WASHINGTON, D.C, DISTRICT OF COLUMBIA, UNITED STATES, May 3, 2024 /EINPresswire.com/ -- The Global …
-
Nanobiotechnology Global Strategic Research Report 2024: Market to Surpass $160 Billion by 2030 from $100 Billion in 2023 as Nanobiotechnology to Become Viable for All Drug Development Stages - ResearchAndMarkets.com
02 May 2024 16:51 GMT
The "Nanobiotechnology - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Nanobiotechnology Market to Reach $160.3 Billion by 2030
The global market for Nanobiotechnology estimated at US$100 …
-
StockWatch: Amgen Throws Its Weight Behind Obesity Drug
05 May 2024 14:39 GMT
Amgen chairman and CEO Robert A. Bradway
Amgen (AMGN) signaled it intends to become the third powerhouse developer in the booming weight loss drug segment on Thursday, as two of its top executives delivered positive comments about the progress of its …
-
The top pharmaceutical companies by R&D expenditure
02 May 2024 09:09 GMT
The year 2023 marked a significant change in the pharmaceutical industry’s landscape as investment in Covid-19 lost prominence in the aftermath of the pandemic and the research and development (R&D) focus shifted to other sectors in the drug …
-
Diving Deep Into Specialty Pharmacy: Insights and Forecasts From IQVIA’s Doug Long
01 May 2024 16:19 GMT
Doug Long, MBA, vice president of industry relations at IQVIA, delivered a comprehensive data-filled overview of industry trends and their impact on the current specialty pharmaceutical industry in his presentation at AXS24, the 20th Asembia summit, “ …
-
The Innovation Game: Who's Winning the Patent Race in America?
04 May 2024 10:48 GMT
2023 was a good year for innovation across the USA. In fact, it was a very good year. It saw a massive increase in the number of major companies filing patents for new technologies and intellectual property rights. But which companies filed the most? And …